Delivery Order SPE2DR25D1100-SPE2DR26FDA0K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,128.30 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with a completion date of August 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order is valued at $41,790.88 with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,125.92 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on September 15, 2025, with completion targeted for September 16, 2025. This non-competitive delivery order utilizes a firm fixed price structure and represents a small-value pharmaceutical supply transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a contract ceiling value of $24,696.38 under a firm fixed-price arrangement. The delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of January 6, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.51 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens (semaglutide) with a completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,410.98 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price delivery order placed without set-aside designation, indicating competitive award. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of...
- The Defense Logistics Agency awarded a delivery order valued at $28,560.25 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on November 20, 2025. This is a firm fixed-price delivery order with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,870.81 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-competitive delivery order represents a firm fixed price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $12,226.99 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $6,644.52 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a completion date of December 2, 2025. The contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA0KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,279.33 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens with a completion date of January 16, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The underlying IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The Zepbound order represents a routine task order fulfillment under this prime vendor agreement, which serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard as part of the broader pharmaceutical supply chain supporting defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 1/14/26 |